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Autoantibodies to the 𝛾-aminobutyric acid receptor, subtype B (GABAB), are a known cause of limbic encephalitis. The spectrum
of clinical manifestations attributable to this antibody is not well defined at the present time. Here we present a case of GABAB
encephalitis presenting with encephalopathy, status epilepticus, dysautonomia, and acute heart failure. To our knowledge, heart
failure and dysautonomia have not yet been reported with this syndrome.
1. Introduction
GABAB encephalitis refers to limbic encephalitis caused by
autoantibodies to the 𝛾-aminobutyric acid receptor, subtype
B (GABAB). Its clinical presentation is similar to other
limbic encephalitides and Morvan syndrome, with psychi-
atric symptoms and seizures predominating. However, the
range of clinical manifestations attributable to this antibody
has not yet been fully described owing primarily to its
recent discovery and its rarity. Here, we present a case of
GABAB encephalitis with additional components of acute
heart failure and dysautonomia.
2. Case Presentation
A previously healthy 52-year-old Caucasian man was admit-
ted to our hospital with a subacute, progressive syn-
drome of refractory seizures, psychosis, dysautonomia, and
encephalopathy. He initially presented to an outside facility
with new-onset seizures, but after multiple hospitalizations,
and despite two antiseizure medications, the patient con-
tinued to have breakthrough seizures. Two weeks later, he
gradually developed amnesia, cognitive difficulties, visual
hallucinations, paranoia, and anxiety, requiring a readmis-
sion to evaluate and treat for a presumed primary psychi-
atric condition. In spite of one month of antiepileptic drug
adjustments he continued to have breakthrough seizures,
prompting transfer to our institution. On exam he was
somnolent with poor attention. He was oriented to self,
location, and year butwas unable to performbasic arithmetic;
the remainder of his neurologic exam was nonfocal.
An infectious etiology was investigated, which included
blood, urine, tracheal aspirate, and CSF cultures, but was
negative. His vital signs were persistently abnormal during
the first ten days after his transfer: temperature up to
38.3∘C, respiratory rate up to 32 breaths per minute, and
sustained heart rates up to 122 beats per minute.The patient’s
hospital course was further complicated by heart failure and
hypotension, necessitating critical care monitoring and an
epinephrine infusion. On presentation to the intensive care
unit his troponin I was 0.26 ng/mL which downtrended to
0.15 ng/mL and was undetectable within 24 hours (the lower
limit of detection on our assay is 0.03 ng/mL). Electrocar-
diograms revealed a supraventricular tachycardia; there were
intermittent episodes of atrial flutter with 2 : 1 atrioventricular
nodal conduction block and atrial fibrillation with rapid
ventricular response (Figure 1). Furthermore, a transthoracic
echocardiogram demonstrated severe mitral regurgitation,
depressed left ventricular function, and an ejection fraction of
26%. Amiodarone and metoprolol were consequently started
with return to normal sinus rhythm.
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Figure 1: Representative electrocardiograms demonstrating tach-
yarrhythmias observed in this case. (a) Supraventricular tachycardia
with a ventricular rate of 195 beats per minute. (b) Atrial fibrillation
with rapid ventricular response. (c) Atrial flutter with a 2 : 1 conduc-
tion block.
A brain MRI showed FLAIR hyperintensities in left
hippocampal body with surrounding mild edema (Figure 2).
Continuous video electroencephalogram monitoring cap-
tured frequent electrographic and clinical seizures of left
posterior temporal onset and moderate to severe generalized
slowing. A lumbar puncture was performed with an opening
pressure of 20 cmH
2
O; cerebrospinal fluid studies showed 4
nucleated cells/𝜇L, protein of 35mg/dL, glucose of 85mg/dL,
and zero oligoclonal bands. Paraneoplastic panel in the
CSF was positive for anti-GABAB receptor antibody. This
antibody panel is performed at the Mayo Clinic Laboratories
(Rochester, MN, USA) and utilizes indirect immunofluores-
cence on animal brain slices to screen for antibodies reactive
to brain antigens. Positive results are further characterized
and reflex tests for other autoreactive antibodies are per-
formed based on the staining pattern. Reflex autoantibody
tests include those against theNMDA receptor, AMPA recep-
tor, and GAD-65 which were not detected; therefore direct
testing for these autoantibodies did not occur. Other relevant
antibodies with this presentation are anti-LGI1 anti-GABAA;
however these were not screened or tested. Negative antibod-
ies on this panel were ANNA-1, ANNA-2, ANNA-3, anti-glial
nuclear antibody, anti-Purkinje cell cytoplasmic antibody,
types 1 and 2 and Tr, anti-amphiphysin, and anti-CRMP-5.
An autoimmune workup was negative for ENA and
ANCA, but with a mildly positive ANA (1 : 160). Anti-thyroid
peroxidase and thyroglobulin antibodies were elevated at
2910 units/mL and 4.8 ng/mL, respectively. These latter two
antibodies are increasingly being appreciated as nonspecific
markers of autoimmune processes in what is often called
“steroid responsive encephalopathy.” Thyroid stimulating
hormone was elevated at 5.78mIU/L, but free T4 was normal
at 1.53 𝜇g/dL. Whole-body CT and PET scan showed no
evidence of malignancy but did reveal markedly increased
FDG uptake within the medial left temporal lobe (Figure 2).
The patient was initially treated with high-dose IV
methylprednisolone at 1 gram per day for six days, in
addition to plasma exchange. Shortly after treatment there
was decreased seizure frequency and continued mainte-
nance of normal sinus rhythm. He was given a dose of
rituximab and started on a twelve-week prednisone taper.
His encephalopathy and psychosis were slower to resolve,
requiring intermittent symptomatic treatment. At the time
of discharge he had no electrographic evidence of epileptic
activity on a regimen of lacosamide, levetiracetam, carba-
mazepine, and scheduled lorazepam. A repeat transthoracic
echocardiogram demonstrated resolution of systolic heart
failure with a normal ejection fraction of 67%. One month
after discharge, a repeat brain MRI revealed a decrease in the
left temporal FLAIR signal; two months after discharge, MRI
revealed complete resolution.
3. Discussion
GABAB encephalitis occurs relatively infrequently; however
the characterization of the antibody and clinical phenotype
has occurred recently. Interestingly, it associated with small
cell lung cancer in 50–80% of patients from recent case series
[1]. This is the most common neoplasm described with this
syndrome and implies that surveillance should continue for
several years after the onset of the encephalitis. By contrast,
dysautonomia occurs more frequently in limbic encephalitis
such as with anti-NMDA autoantibodies [2]. Ho¨ftberger
et al. have previously reported autonomic dysfunction in
one of twenty patients with GABAB syndrome [3]. We are
not aware of acute heart failure in the context of GABAB
encephalitis, though there is at least one report of Takotsubo
cardiomyopathy in a patient with limbic encephalitis [4].This
was presumed to be a paraneoplastic process associated with
B cell lymphoma but unfortunately an autoantibody was not
identified. Cardiogenic shock and heart failure have also been
seen in rhombencephalitis caused by enterovirus 71 [5]. In
that report there was no PCR evidence of enterovirus 71 in
seven hearts examined for pathology. Similarly there was
no significant cardiac inflammatory infiltrate, all suggesting
that heart failure was due to a neurogenic mechanism rather
thanmyocarditis.The cardiac dysfunction seen in these cases
globally affected the left ventricle, similar to the patient
described in the present report.
Although the known etiologies of supraventricular tachy-
cardia and acute heart failure are numerous and varied,
the clinical circumstances in this case strongly suggest that
they were a consequence of neurologic injury. Three points
when taken together support this: (1) GABAB receptors are
transcribed in the fetal but not adult heart and are thought
to be found primarily in the nervous system, though they
have recently been described in smoothmuscle of the human
aorta [6, 7]; (2) the cardiomyopathy persisted until the
patient underwent immunosuppressive treatment and then
fully resolved with treatment; (3) there are few etiologies of
his cardiomyopathy identified which would be expected to
resolve with immunosuppression or spontaneously, though
autoimmune myocarditis or tachycardia-induced cardiomy-
opathy is among them.
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Figure 2: (a) Axial PET demonstrating significant uptake of FDG in the left mesial temporal lobe. (b) Coronal FLAIR MRI with subtle
hyperintensity surrounding the left hippocampus (arrowhead).
In our patient there was hypermetabolism in the left
medial temporal lobe, determined by FDG PET imaging
which is suggestive of inflammation. This is consistent with
limbic encephalitides that have been reported in the liter-
ature. While common, it is not a uniform finding. Indeed,
hypermetabolism has been reported in the bilateral medial
temporal lobes, occipital lobes, frontal lobes, and cerebellum.
There are also cases of hypometabolism though this seems to
occur in older patients andmay be associatedwith concurrent
neurodegenerative processes [8].The specific brain structures
that are inflamed are expected to relate to the clinical mani-
festations of the limbic encephalitis. For example, our patient
had prominent difficulty with cognitive function, seizures,
and hallucinations, all of which could be attributed to the
temporal lobe or via its connections. Similar presentations
of GABAB encephalitis have been described in a recent large
case series [3].
The connections between the medial temporal lobe and
the insular cortex provide one pathway by which limbic
encephalitis can lead to dysautonomia [4, 9]. The insular
cortex is known to modulate autonomic pathways from the
brain to the heart. For example, cardiac complications such
as arrhythmias, myocardial infarction, and heart failure are
reported after left insular stroke as well as intracerebral
and subarachnoid hemorrhages [10, 11]. Additionally, other
stroke locations such as hemispheric and basal ganglia as
well as epilepsy have also been associated with heart failure,
suggesting that there are many connections involved in
neural regulation of the heart [12, 13]. Further support of a
neural-mediated cardiac injury in this patient is promoted
by animal studies where baclofen injection into the tract of
the nucleus solitarius produced hypertension and tachycardia
and inhibited the depressor baroreflex response [14]. Others
have similarly found that vagal inhibition by the solitary tract
is mediated by both GABAA and GABAB receptors [15].
Onemechanism of heart failure and dysautonomia in this
case may be due to blockade GABAB receptors in the brain-
stem, ultimately leading to failure of vagal inhibition of car-
diac function.Another possibility is that thiswas tachycardia-
associated cardiomyopathy, which in turn could be due to
dysautonomia caused by the limbic encephalitis. Alternative
explanations for our patient’s heart failure include direct
antibody mediated effects on the myocardium. However,
there are no reports of GABA receptors in the myocardium.
Also, anti-thyroid peroxidase antibodies are not associated
with heart failure [16, 17]. Nonetheless, we can only speculate
about the precise pathogenesis of heart failure. A cardiacMRI
or myocardial biopsy would have been helpful in identifying
an autoimmune myocarditis, due to either anti-GABAB
antibodies biding to sites other than the GABAB receptor or
additional antibodies that we did not detect. Fortunately, the
patient’s cardiac function was improving with treatment and
we did not feel that further diagnostic testing of the heart
would change management; therefore it was not pursued.
Takotsubo cardiomyopathy, the most widely recognized
to be associatedwith neurologic injury, is thought to bemedi-
ated by increased levels of circulating catecholamines and in
turn increases in intracellular calcium and in systemic vascu-
lar resistance and afterload [12, 18]. Takotsubo cardiomyopa-
thy is primarily characterized by apical ballooning, a feature
that was absent in this case [19]. As such, this entity is unlikely
in our patient, who instead had global systolic dysfunction.
In this report we highlight two uncommon complications
of GABAB encephalitis: acute heart failure and dysautono-
mia. To our knowledge, cardiomyopathy has not previously
been recognized as a manifestation of this condition and
dysautonomia is uncommon [20]. GABAB encephalitis is
associated with a varied clinical phenotype. We believe that
this report further expands the clinical manifestations of this
relatively uncommon syndrome.
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